TEMPO: Transformers for Temporal Disease Progression from Cross-Sectional Data
Abstract
Event-Based Models (EBMs) infer biomarker progression from cross-sectional data but typically only as ordinal sequences and rely on rigid model assumptions. We propose Tempo, a Transformer architecture that learns both ordinal and continuous event sequences through simulation-based supervised learning. Tempo uses two Transformer modules: one treats biomarkers as tokens to infer event sequencing; the other treats patients as tokens, representing each by their per-biomarker abnormality profile, to infer patients' disease stages. On synthetic benchmarks, Tempo reduces normalized Kendall's Tau distance by 52.89\% and staging MAE by 25.33\% compared to state-of-the-art SA-EBM, with larger reductions in high-dimensional settings (58.88\% and 61.10\%). Applied to ADNI, Tempo recovers a biologically plausible Alzheimer's progression: early medial temporal atrophy, followed by amyloid accumulation and cognitive decline, and late-stage tau pathology with terminal acceleration of global neurodegeneration -- broadly consistent with established disease models. Tempo also eliminates the need to derive custom inference algorithms and enables rapid empirical comparison of generative hypotheses.
Turn this paper into a lesson
ArcXiv compiles a structured reading guide from this paper's metadata: plain-English importance, contributions, prerequisite concepts, which sections to read first, flashcards, and a quiz. Grounded in the abstract, never invented.